Compound Detail
CHEMBL4129018
MW-150 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL4129018 |
| Name | MW-150 |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | CIIVUDIZZJLXCN-UHFFFAOYSA-N |
3
Targets
5
Activities
2
Assay Types
30
PK Parameters
20
Publications
3
Known Names
1
Indications
Molecular Properties
381.5
MW (Da)
4.11
ALogP
5
HBA
0
HBD
45.1
PSA (Ų)
0.53
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Indications
Alzheimer Disease
Activity Summary
IC50 4 meas. best 6.64
Ki 1 meas. best 7.0
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Mitogen-activated protein kinase 14 CHEMBL260 | Ki | 7.0 | 7.0 | 100.0 | 1 |
| Mitogen-activated protein kinase 14 CHEMBL260 | IC50 | 6.64 | 6.64 | 230.0 | 2 |
| Mitogen-activated protein kinase 11 CHEMBL3961 | IC50 | 5.73 | 5.73 | 1850.0 | 1 |
| Casein kinase I isoform delta CHEMBL2828 | IC50 | 5.58 | 5.58 | 2610.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 739.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 2601.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 3841.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 2035.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 6632.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 10615.0 | ng.hr.mL-1 | Rattus norvegicus |
| CL | 24.33 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 28.5 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 11.28 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 13.6 | mL.min-1.kg-1 | Rattus norvegicus |
| Cmax | 581.94 | nM | Rattus norvegicus |
| Cmax | 1027.58 | nM | Rattus norvegicus |
| Cmax | 1701.27 | nM | Rattus norvegicus |
| Cmax | 951.56 | nM | Rattus norvegicus |
| Cmax | 1693.4 | nM | Rattus norvegicus |
| Cmax | 3153.51 | nM | Rattus norvegicus |
| F | 53.0 | % | Rattus norvegicus |
| F | 55.1 | % | Rattus norvegicus |
| F | 67.8 | % | Rattus norvegicus |
| F | 70.7 | % | Rattus norvegicus |
| T1/2 | 1.0 | hr | Homo sapiens |
| T1/2 | 2.07 | hr | Rattus norvegicus |
| T1/2 | 3.13 | hr | Rattus norvegicus |
| T1/2 | 2.87 | hr | Rattus norvegicus |
| T1/2 | 2.38 | hr | Rattus norvegicus |
| T1/2 | 3.47 | hr | Rattus norvegicus |
| T1/2 | 3.73 | hr | Rattus norvegicus |
| T1/2 | 4.71 | hr | Rattus norvegicus |
| T1/2 | 5.07 | hr | Rattus norvegicus |
| T1/2 | 3.73 | hr | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Mitogen-activated protein kinase 14 | Ki | = | 100.0 | nM | 7.0 | Inhibition of human p38alpha | 30978288 |
| Mitogen-activated protein kinase 14 | IC50 | = | 230.0 | nM | 6.64 | Inhibition of human p38alpha | 30978288 |
| Mitogen-activated protein kinase 14 | IC50 | = | 230.0 | nM | 6.64 | Antagonist activity at p38 MAPK alpha (unknown origin) | 33974419 |
| Mitogen-activated protein kinase 11 | IC50 | = | 1850.0 | nM | 5.73 | Inhibition of human p38beta | 30978288 |
| Casein kinase I isoform delta | IC50 | = | 2610.0 | nM | 5.58 | Inhibition of human CK1delta | 30978288 |
Literature References
Data from ChEMBL 36 via Core Engine